Our Pricing

Wegovy & Ozempic Alternatives: Real UK Weight Loss Results

Published on: June 03, 2026

Searching for wegovy and ozempic alternatives uk with clinically proven results? At Cured Pharmacy, we provide access to UK-licensed semaglutide weight loss injections from £79.00 supported by free clinical consultations with our UK-registered prescribers. Our transparent pricing and discreet service help thousands of UK patients achieve meaningful weight loss outcomes.

Understanding Semaglutide Weight Loss Injections

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone your body produces after eating. It works by slowing gastric emptying, reducing appetite, and improving blood sugar regulation — three mechanisms that work together to support weight loss [1]. Originally developed for type 2 diabetes management, semaglutide has become one of the most effective weight loss treatments available in the UK.

Clinical trials demonstrate that semaglutide can help patients achieve substantial weight reduction when combined with lifestyle modifications. The STEP 1 trial showed participants lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo [2]. These results represent some of the most significant weight loss outcomes observed in pharmaceutical trials, which is why semaglutide-based treatments have transformed weight management in UK clinical practice.

Wegovy and Ozempic Alternatives UK: What Are Your Options?

Both Wegovy and Ozempic contain the same active ingredient — semaglutide — but they're licensed for different purposes by the MHRA. Wegovy is specifically licensed for chronic weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions. Ozempic, whilst containing identical semaglutide, is licensed primarily for type 2 diabetes management, though it produces similar weight loss effects.

At Cured Pharmacy, we provide access to Wegovy injections following clinical assessment by our UK prescribers. The treatment involves once-weekly subcutaneous injections, starting at a lower dose and gradually increasing over 16-20 weeks to minimise gastrointestinal side effects [3]. This titration schedule is crucial for tolerability and helps patients adapt to the medication's effects on appetite and digestion.

How Wegovy Differs from Ozempic in UK Practice

Whilst both medications contain semaglutide, Wegovy reaches a maximum maintenance dose of 2.4mg weekly, whereas Ozempic's highest licensed dose for diabetes is 1mg weekly (though 2mg is available). Wegovy's dosing schedule is specifically optimised for weight management, with a structured escalation protocol that UK prescribers follow. Your clinical assessment will determine which treatment is most appropriate based on your medical history, current medications, and weight loss goals.

Real UK Weight Loss Results: What Clinical Trials Show

The STEP clinical trial programme provides robust evidence for semaglutide's efficacy in weight management. In STEP 1, participants receiving 2.4mg weekly semaglutide lost an average of 14.9% body weight over 68 weeks, with 86.4% of participants achieving at least 5% weight loss — the threshold considered clinically meaningful [2]. More impressively, 69.1% achieved at least 10% weight loss, and 50.5% lost 15% or more of their starting body weight.

These results represent substantial improvements over previous weight loss medications. For context, earlier pharmaceutical options typically produced 5-10% weight loss in clinical trials. The STEP trials also demonstrated improvements in cardiometabolic markers, including blood pressure, lipid profiles, and glycaemic control in participants with prediabetes [4]. UK prescribers now have strong evidence supporting semaglutide as a first-line pharmacological option for weight management, subject to appropriate patient selection and monitoring.

Long-Term Weight Maintenance with Semaglutide

The STEP 4 trial examined what happens when patients discontinue semaglutide after achieving weight loss. Participants who stopped treatment regained approximately two-thirds of their lost weight over 52 weeks, whilst those who continued maintained their weight loss [4]. This finding highlights that semaglutide works best as part of a long-term weight management strategy, combined with sustained lifestyle modifications including dietary changes and increased physical activity.

How to Start Wegovy Treatment at Cured Pharmacy

Starting your weight loss journey with Cured Pharmacy is straightforward and completely online. Begin by completing our free clinical consultation questionnaire, which takes under three minutes. You'll provide information about your medical history, current medications, previous weight loss attempts, and any existing health conditions. Our UK-registered prescribers review every submission individually to ensure semaglutide is safe and appropriate for you.

If approved, your prescription is sent to our UK-registered pharmacy team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispense only genuine UK-licensed Wegovy pens and arrange discreet delivery to your address. Your medication arrives in plain, unmarked packaging with no external indication of contents. We also provide ongoing support throughout your treatment, with access to our clinical team for any questions or concerns about side effects, dosing, or injection technique.

Wegovy and Ozempic Alternatives: Managing Side Effects

The most common side effects of semaglutide are gastrointestinal and include nausea, diarrhoea, constipation, vomiting, and abdominal discomfort. These effects are typically mild to moderate and diminish over time as your body adjusts to the medication [1]. The gradual dose escalation protocol is specifically designed to minimise these symptoms — this is why Wegovy starts at 0.25mg weekly and increases slowly over several months.

To reduce gastrointestinal side effects, UK prescribers recommend eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and not lying down immediately after eating. Most patients find these symptoms improve significantly after the first 4-8 weeks. However, if you experience severe or persistent vomiting, signs of pancreatitis (severe abdominal pain radiating to your back), or symptoms of gallbladder problems, you should contact a healthcare professional immediately. Our clinical team at Cured Pharmacy is available to discuss any concerns during your treatment.

Rare but Serious Side Effects to Monitor

Whilst uncommon, semaglutide carries warnings for several serious conditions. These include acute pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal side effects), and hypoglycaemia when used with other diabetes medications [3]. There's also a theoretical risk of thyroid C-cell tumours based on animal studies, though this hasn't been observed in human trials. Your prescriber will assess your individual risk factors during consultation, and semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Who Can Use Wegovy and Ozempic Alternatives in the UK?

NICE guidelines recommend considering GLP-1 receptor agonists like semaglutide for adults with a BMI of 35 or above, or 32.5 or above for people from Black, Asian, or other minority ethnic groups who are at equivalent risk at lower BMI thresholds. Semaglutide may also be appropriate for individuals with BMI 30-34.9 (or 27.5-32.4 for at-risk ethnic groups) who have weight-related comorbidities such as hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease [3].

However, semaglutide isn't suitable for everyone. It's contraindicated in pregnancy and breastfeeding, and women of childbearing potential should use effective contraception during treatment. You shouldn't use semaglutide if you have a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or a history of severe gastrointestinal disease including inflammatory bowel disease. Your UK prescriber will review your full medical history during consultation to determine if semaglutide is appropriate and safe for you. All prescription medications dispensed by Cured Pharmacy require prior approval from our UK-registered clinical team.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
3. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.